Learning from our foes: a novel vaccine concept for influenza virus
Concerted efforts to study the molecular biology of influenza viruses and the ability to genetically engineer them have dramatically advanced our understanding of the functions of influenza viral genes and gene products. The only nonstructural protein (NS1 ) coded for by the influenza virus was shown to possess interferon antagonist activity and thus to play an important role in countering the interferon (antiviral) response of the host following infection. Influenza A and B virus mutants with “weak” anti-interferon activity are highly attenuated because the host is able to mount an effective interferon response. It is suggested that these NS1-modified attenuated influenza viruses can induce a protective immune response and that they are ideal live virus vaccine candidates against influenza.
KeywordsInfluenza Virus Vaccine Strain Wild Type Virus Interferon Response Influenza Virus Vaccine
Unable to display preview. Download preview PDF.
- 1.Basler C, Palese P (1999) Influenza viruses. In: Lederberg J (ed) Encyclopedia of microbiology. Academic Press, San Diego (in press)Google Scholar
- 3.Donnelly JJ, Ulmer JB, Liu MA (1998) DNA vaccines. Dev Biol Standards 95: 43–53Google Scholar
- 4.Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE (1998b) The role of interferon in influenza virus tissue tropism. J Virol 72: 8 550–8 558Google Scholar
- 6.Hatada E, Saito S, Fukuda R (1999) Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol 73: 2 425–2 423Google Scholar
- 7.Hayden FG, Palese P (1997) Influenza virus. In: Richman DD, Whitley RJ, Hay den FG (eds) Clinical virology. Churchill Livingstone, New York, pp 911–942Google Scholar
- 10.Krug RM (1999) Unique functions of the NS1 protein. In: Nicholson KG, Webster RG, Hay AJ (eds) Textbook of influenza. Blackwell, Oxford, pp 82–92Google Scholar
- 11.Lamb RA, Krug RM (1996) Orthomyxoviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Virology, 3rd ed. Lippincott-Raven, Philadelphia, pp 1 353–1 395Google Scholar
- 13.Maassab HF, LaMontagne JR, DeBorde DC (1998) Live influenza virus vaccines. In: Plotkin SA, Mortimer EA (eds) Vaccines. Saunders, Philadelphia, pp 435–457Google Scholar
- 14.Marion RM, Fortes P, Beloso A, Dotti C, Ortin J (1999) A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum. Mol Cell Biol 19: 2 212–2 219Google Scholar
- 16.Murphy BR, Webster RG (1996) Orthomyxoviruses In: Fields BN, Knipe DM, Howley PM (eds) Virology, 3rd ed. Lippincott-Raven, Philadelphia, pp 1397–1445Google Scholar
- 20.Wolff T, O’Neill RE, Palese P (1996) Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses. J Virol 70: 5 363–72Google Scholar
- 21.Wolff T, O’Neill RE, Palese P (1998) NSl-binding protein (NS1-BP): A novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nucleus of infected cells. J Virol 72: 7 170–7 180Google Scholar